Publication:
Outcomes of SARS-CoV-2 infected pregancies after medically assisted reproduction

dc.contributor.coauthorGianaroli, Luca
dc.contributor.coauthorLundin, Kersti
dc.contributor.coauthorMcheik, Saria
dc.contributor.coauthorMocanu, Edgar
dc.contributor.coauthorRautakallio-Hokkanen, Satu
dc.contributor.coauthorTapanainen, Juha S.
dc.contributor.coauthorVermeulen, Nathalie
dc.contributor.coauthorVeiga, Anna
dc.contributor.coauthorEshre COVID-19 Working Group
dc.contributor.kuauthorAta, Mustafa Barış
dc.contributor.kuprofileFaculty Member
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.yokid182910
dc.date.accessioned2024-11-09T13:47:21Z
dc.date.issued2022
dc.description.abstractStudy question: what is the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on the outcome of a pregnancy after medically assisted reproduction (MAR)?. Summary answer: our results suggest that MAR pregnancies are not differentially affected by SARS-CoV-2 infection compared to spontaneous pregnancies. What is known already: information on the effects of coronavirus disease 2019 (COVID-19) on pregnancy after MAR is scarce when women get infected during MAR or early pregnancy, even though such information is vital for informing women seeking pregnancy. Study design, size, duration: data from SARS-CoV-2 affected MAR pregnancies were collected between May 2020 and June 2021 through a voluntary data collection, organised by the European Society of Human Reproduction and Embryology (ESHRE). Participants/materials, setting, methods: all ESHRE members were invited to participate to an online data collection for SARS-CoV-2-infected MAR pregnancies. Main results and the role of chance: the dataset includes 80 cases from 32 countries, including 67 live births, 10 miscarriages, 2 stillbirths and 1 maternal death. An additional 25pregnancies were ongoing at the time of writing. Limitations, reasons for caution: an international data registry based on voluntary contribution can be subject to selective reporting with possible risks of over- or under-estimation. Wider implications of the findings: the current data can be used to guide clinical decisions in the care of women pregnant after MAR, in the context of the COVID-19 pandemic.
dc.description.fulltextYES
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue11
dc.description.openaccessYES
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipN/A
dc.description.versionPublisher version
dc.description.volume36
dc.formatpdf
dc.identifier.doi10.1093/humrep/deab218
dc.identifier.eissn1460-2350
dc.identifier.embargoNO
dc.identifier.filenameinventorynoIR03201
dc.identifier.issn0268-1161
dc.identifier.linkhttps://doi.org/10.1093/humrep/deab218
dc.identifier.quartileQ1
dc.identifier.scopus2-s2.0-85119303885
dc.identifier.urihttps://hdl.handle.net/20.500.14288/3762
dc.identifier.wos743765900008
dc.keywordsSARS-CoV-2
dc.keywordsCOVID-19
dc.keywordsMedically assisted reproduction
dc.keywordsESHRE
dc.keywordsPregnancy
dc.keywordsIVF
dc.languageEnglish
dc.publisherOxford University Press (OUP)
dc.relation.grantnoNA
dc.relation.urihttp://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/9963
dc.sourceHuman Reproduction
dc.subjectObstetrics and gynecology
dc.subjectReproductive biology
dc.titleOutcomes of SARS-CoV-2 infected pregancies after medically assisted reproduction
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.authorid0000-0003-1106-3747
local.contributor.kuauthorAta, Mustafa Barış

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
9963.pdf
Size:
344.88 KB
Format:
Adobe Portable Document Format